A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)
NCT02121782
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Quadrivalent influenza vaccine
BIOLOGICAL:
Trivalent influenza vaccine
Sponsor
Green Cross Corporation